For the year ending 2025-12-31, WGS made $427,539K in revenue. -$20,915K in net income. Net profit margin of -4.89%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 427,539 | 302,157 | ||
| Cost of services | 129,366 | 111,053 | ||
| Gross profit | 298,173 | 194,397 | ||
| Research and development | 72,026 | 45,722 | ||
| Selling and marketing | 88,405 | 67,371 | ||
| General and administrative | 150,819 | 101,110 | ||
| Impairment loss | 0 | - | ||
| Other operating expenses, net | 0 | -3,407 | ||
| Loss from operations | -13,077 | -23,213 | ||
| Change in fair value of financial liabilities | -1,204 | - | ||
| Change in fair value of warrants and contingent liabilities | - | -13,370 | ||
| Interest (expense) income, net | -2,539 | -3,032 | ||
| Other (expense) income, net | -4,317 | -13,014 | ||
| Total non-operating (expense) income, net | -8,060 | -29,416 | ||
| Loss before income taxes | -21,137 | -52,629 | ||
| Income tax benefit | -116 | -343 | ||
| Net loss | -21,021 | -52,286 | ||
| Unrealized gain related to available for sale securities, net | 106 | 405 | ||
| Comprehensive loss | -20,915 | -51,881 | ||
| Basic EPS | -0.73 | -1.94 | ||
| Diluted EPS | -0.73 | -1.94 | ||
| Basic Average Shares | 28,641,734 | 26,891,213 | ||
| Diluted Average Shares | 28,641,734 | 26,891,213 | ||
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)